Athersys shares rebound somewhat since falling by two-thirds on clinical trial results
June 17, 2022 at 14:55 PM EDT
Athersys plans to ask shareholders to approve a reverse stock split of its shares.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|